Home
/
InfuSystem Holdings, Inc
/
Financials
/
Quarterly
InfuSystem Holdings, Inc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that InfuSystem Holdings, Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$36.49M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$36.00M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$34.72M
May 8, 2025
Q3
2025
Sep 30, 2024
$35.32M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$33.70M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$32.00M
May 8, 2025
Q3
2024
Sep 30, 2023
$31.91M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$31.74M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$30.37M
May 9, 2024
Q3
2023
Sep 30, 2022
$27.28M
Nov 9, 2023
Q2
2023
Jun 30, 2022
$27.04M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$26.76M
May 9, 2023
Q3
2022
Sep 30, 2021
$26.57M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$24.83M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$24.46M
May 5, 2022
Q3
2021
Sep 30, 2020
$25.13M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$26.00M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$21.55M
May 10, 2021
Q3
2020
Sep 30, 2019
$21.49M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$19.72M
Aug 14, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$17.59M
Nov 13, 2017
Q2
2017
Jun 30, 2017
$16.94M
Aug 9, 2017
Q1
2017
Mar 31, 2017
$17.65M
May 15, 2017
Q3
2017
Sep 30, 2016
$17.23M
Nov 13, 2017
Q2
2017
Jun 30, 2016
$18.12M
Aug 9, 2017
Q1
2017
Mar 31, 2016
$18.29M
May 15, 2017
Q3
2016
Sep 30, 2015
$18.31M
Dec 12, 2016
Q2
2016
Jun 30, 2015
$16.94M
Dec 12, 2016
Q1
2016
Mar 31, 2015
$16.55M
Dec 12, 2016
Q3
2015
Sep 30, 2014
$16.61M
Nov 12, 2015
Q2
2015
Jun 30, 2014
$16.37M
Aug 13, 2015
Q1
2015
Mar 31, 2014
$17.24M
May 12, 2015
Q3
2014
Sep 30, 2013
$15.74M
Nov 10, 2014
Q2
2014
Jun 30, 2013
$14.66M
Aug 1, 2014
Q1
2014
Mar 31, 2013
$14.70M
May 5, 2014
Q3
2013
Sep 30, 2012
$14.18M
Nov 12, 2013
Q2
2013
Jun 30, 2012
$14.07M
Aug 13, 2013
Q1
2013
Mar 31, 2012
$14.35M
May 13, 2013
Q3
2012
Sep 30, 2011
$14.51M
Nov 14, 2012
Q2
2012
Jun 30, 2011
$13.13M
Aug 8, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.26M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$2.60M
Aug 5, 2025
Q1
2025
Mar 31, 2025
($267.0K)
May 8, 2025
Q3
2025
Sep 30, 2024
$1.81M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$717.0K
Aug 5, 2025
Q1
2025
Mar 31, 2024
($1.11M)
May 8, 2025
Q3
2024
Sep 30, 2023
$689.0K
Nov 8, 2024
Q2
2024
Jun 30, 2023
$435.0K
Aug 9, 2024
Q1
2024
Mar 31, 2023
($324.0K)
May 9, 2024
Q3
2023
Sep 30, 2022
$443.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
($164.0K)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($368.0K)
May 9, 2023
Q3
2022
Sep 30, 2021
($448.0K)
Nov 8, 2022
Q2
2022
Jun 30, 2021
$820.0K
Aug 4, 2022
Q1
2022
Mar 31, 2021
$661.0K
May 5, 2022
Q3
2021
Sep 30, 2020
$2.94M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$4.14M
Aug 12, 2021
Q1
2021
Mar 31, 2020
($418.0K)
May 10, 2021
Q3
2020
Sep 30, 2019
$1.14M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$381.0K
Aug 14, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$3.81M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$3.78M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$618.0K
May 8, 2025
Q3
2025
Sep 30, 2024
$3.27M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$1.86M
Aug 5, 2025
Q1
2025
Mar 31, 2024
($845.0K)
May 8, 2025
Q3
2024
Sep 30, 2023
$1.70M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$1.25M
Aug 9, 2024
Q1
2024
Mar 31, 2023
($107.0K)
May 9, 2024
Q3
2023
Sep 30, 2022
$943.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$207.0K
Aug 9, 2023
Q1
2023
Mar 31, 2022
($525.0K)
May 9, 2023
Q3
2022
Sep 30, 2021
($351.0K)
Nov 8, 2022
Q2
2022
Jun 30, 2021
$696.0K
Aug 4, 2022
Q1
2022
Mar 31, 2021
$873.0K
May 5, 2022
Q3
2021
Sep 30, 2020
$3.25M
Nov 15, 2021
Q2
2021
Jun 30, 2020
$4.51M
Aug 12, 2021
Q1
2021
Mar 31, 2020
$33.0K
May 10, 2021
Q3
2020
Sep 30, 2019
$1.66M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$971.0K
Aug 14, 2020